Patent details
EP2167066 Title: DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF ATTENTION DEFICIT DISORDERS
Basic Information
- Publication number:
- EP2167066
- PCT Application Number:
- PCT/US/2008/062879
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP087693115
- PCT Publication Number:
- WO/2008/137923
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF ATTENTION DEFICIT DISORDERS
- French Title of Invention:
- DROXIDOPA ET COMPOSITION PHARMACEUTIQUE DE CELLE-CI POUR LE TRAITEMENT DE TROUBLES DÉFICITAIRES DE L'ATTENTION
- German Title of Invention:
- DROXIDOPA UND PHARMAZEUTISCHE ZUSAMMENSETZUNG DAVON ZUR BEHANDLUNG VON AUFMERKSAMKEITSDEFIZIT-STÖRUNGEN
- SPC Number:
Dates
- Filing date:
- 07/05/2008
- Grant date:
- 26/06/2013
- EP Publication Date:
- 26/06/2013
- PCT Publication Date:
- 13/11/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 31/03/2010
- EP B1 Publication Date:
- 26/06/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 07/05/2014
- Expiration date:
- 07/05/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/05/2008
- Name:
- Chelsea Therapeutics Inc.
- Address:
- 3530 Toringdon Way Suite 200, Charlotte, NC 28277, United States (US)
Inventor
1
- Name:
- ROBERTS Michael, J.
- Address:
- United States (US)
2
- Name:
- PEDDER Simon
- Address:
- United States (US)
Priority
- Priority Number:
- 916497 P
- Priority Date:
- 07/05/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/198;
| Filing date | Document type | Number of pages |
|---|